AngioDynamics, Inc.
ANGO · NASDAQ
8/31/2025 | 5/31/2025 | 2/28/2025 | 11/30/2024 | |
|---|---|---|---|---|
| Revenue | $75,711 | $80,158 | $72,004 | $72,845 |
| % Growth | -5.5% | 11.3% | -1.2% | – |
| Cost of Goods Sold | $33,854 | $37,940 | $33,147 | $32,939 |
| Gross Profit | $41,857 | $42,218 | $38,857 | $39,906 |
| % Margin | 55.3% | 52.7% | 54% | 54.8% |
| R&D Expenses | $6,417 | $6,590 | $6,913 | $6,434 |
| G&A Expenses | $12,555 | $10,236 | $10,490 | $10,391 |
| SG&A Expenses | $40,685 | $36,673 | $35,994 | $35,980 |
| Sales & Mktg Exp. | $28,130 | $26,437 | $25,504 | $25,589 |
| Other Operating Expenses | $5,411 | $4,743 | $5,924 | $8,586 |
| Operating Expenses | $52,513 | $48,006 | $48,831 | $51,000 |
| Operating Income | -$10,656 | -$5,788 | -$9,974 | -$11,094 |
| % Margin | -14.1% | -7.2% | -13.9% | -15.2% |
| Other Income/Exp. Net | -$182 | -$322 | $5,565 | $246 |
| Pre-Tax Income | -$10,838 | -$6,110 | -$4,409 | -$10,848 |
| Tax Expense | $65 | -$60 | -$2 | -$110 |
| Net Income | -$10,903 | -$6,050 | -$4,407 | -$10,738 |
| % Margin | -14.4% | -7.5% | -6.1% | -14.7% |
| EPS | -0.26 | -0.15 | -0.11 | -0.26 |
| % Growth | -73.3% | -36.4% | 57.7% | – |
| EPS Diluted | -0.26 | -0.15 | -0.11 | -0.26 |
| Weighted Avg Shares Out | 41,174 | 40,984 | 40,853 | 40,922 |
| Weighted Avg Shares Out Dil | 41,174 | 40,984 | 40,853 | 40,922 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $3 | $135 | $234 |
| Interest Expense | $4 | $0 | $0 | $0 |
| Depreciation & Amortization | $6,020 | $5,833 | $6,319 | $6,863 |
| EBITDA | -$4,814 | $2,200 | -$329 | $1,793 |
| % Margin | -6.4% | 2.7% | -0.5% | 2.5% |